Enhanced myocardial fluorodeoxyglucose uptake following Adriamycin-based therapy: Evidence of early chemotherapeutic cardiotoxicity?

Table 1 The mean dose of adriamycin received and changes in cardiac SUVmean values on pre- and post-therapy fluorodeoxyglucose positron emission tomography scans of patients in groups A, B and C

Group of patients	n	Mean dose of adriamycin (mg/m2)	Mean duration in days since last chemotherapy to PET scan	Mean difference in cardiac SUVmean (preRx-postRx)
Group A	8	256.25	15.12	4.668
Group B	6	250	21.5	Nil
Group C	4	137.5	18.5	-4.138

SUV: Standard uptake values; PET: Positron emission tomography.